Technical Analysis for VOR - Vor Biopharma Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 19.7 | -7.51% | -1.60 |
VOR closed down 7.51 percent on Thursday, May 13, 2021, on 70 percent of normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | Down | Down |
| Historical VOR trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 0.00% | |
| Expansion Breakdown | Bearish Swing Setup | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| New 52 Week Low | Weakness | 0.00% | |
| Multiple of Ten Bearish | Other | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Below Lower BB | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| New 52 Week Closing Low | Bearish | -7.51% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| Down 10% | about 7 hours ago |
| Down 5% | about 9 hours ago |
| Down 3% | about 9 hours ago |
| Down 2 % | about 9 hours ago |
| 60 Minute Opening Range Breakdown | about 9 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: ???
Vor Biopharma, Inc. develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It offers VOR33, an eHSC product candidate that is in preclinical development to treat acute myeloid leukemia (AML). The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AML cancer cells. Vor Biopharma, Inc. was incorporated in 2015 and is based in Cambridge, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Acute Myeloid Leukemia Tyrosine Kinase Receptors Therapies For Cancer Proteins Haematopoiesis
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Acute Myeloid Leukemia Tyrosine Kinase Receptors Therapies For Cancer Proteins Haematopoiesis
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 63.62 |
| 52 Week Low | 18.685 |
| Average Volume | 200,677 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 33.09 |
| 20-Day Moving Average | 26.67 |
| 10-Day Moving Average | 24.44 |
| Average True Range | 3.29 |
| ADX | 24.14 |
| +DI | 9.52 |
| -DI | 27.77 |
| Chandelier Exit (Long, 3 ATRs ) | 24.51 |
| Chandelier Exit (Short, 3 ATRs ) | 28.56 |
| Upper Bollinger Band | 32.81 |
| Lower Bollinger Band | 20.53 |
| Percent B (%b) | -0.07 |
| BandWidth | 46.05 |
| MACD Line | -3.47 |
| MACD Signal Line | -3.07 |
| MACD Histogram | -0.3956 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 26.15 | ||||
| Resistance 3 (R3) | 26.52 | 24.75 | 25.07 | ||
| Resistance 2 (R2) | 24.75 | 23.11 | 24.56 | 24.71 | |
| Resistance 1 (R1) | 22.23 | 22.10 | 21.34 | 21.85 | 24.36 |
| Pivot Point | 20.46 | 20.46 | 20.01 | 20.27 | 20.46 |
| Support 1 (S1) | 17.93 | 18.81 | 17.04 | 17.55 | 15.04 |
| Support 2 (S2) | 16.16 | 17.80 | 15.97 | 14.69 | |
| Support 3 (S3) | 13.63 | 16.16 | 14.33 | ||
| Support 4 (S4) | 13.25 |
